Micro-CT molecular imaging of tumor angiogenesis using a magnetite nano-cluster probe

Journal of Biomedical Nanotechnology

Volumn 9, Issue 6, 2013, Pages 1041-1049

  Liu, Ping ^a   Li, Jing ^a   Zhang, Chunfu ^a   Xu, Lisa X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiogenesis; Iron oxide nanoparticles; Micro CT; Molecular imaging

Indexed keywords

ANGIOGENESIS; DIRECT VISUALIZATION; DYNAMIC MONITORING; HYDRODYNAMIC SIZE; INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETER; IRON OXIDE NANOPARTICLE; MICRO CT; TUMOR ANGIOGENESIS;

ETHYLENE GLYCOL; MAGNETITE; MOLECULAR IMAGING; MOTION PICTURE EXPERTS GROUP STANDARDS; NANOCLUSTERS; PEPTIDES; POLLUTION DETECTION; PROBES; TUMORS;

COMPUTERIZED TOMOGRAPHY;

COPOLYMER; MAGNETITE NANOPARTICLE; MALEIMIDE; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CARCINOGENESIS; DRUG CONJUGATION; DRUG TARGETING; HUMAN; HUMAN CELL; MICRO-COMPUTED TOMOGRAPHY; MOLECULAR IMAGING; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; LUNG NEOPLASMS; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84877814287     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1604     Document Type: Article

References (45)

1. P. Carmeliet and R. K. Jain, Angiogenesis in cancer and other diseases. Nature 407, 249 (2000).
2. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27 (1995).
3. J. F. A. Jansen, J. A. Koutcher, and A. Shukla-Dave, Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis (2010), Doi 10.1007/s10456-010-9167-z.
4. E. R. Horak, R. Leek, and N. Klenk, Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340, 1120 (1992).
5. D. Meitar, S. E. Crawford, A. W. Rademaker, and S. L. Cohn, Tumor angiogenesis correlates with metastatic disease, N-myc amplification and poor outcome in human neuroblastoma. J. Clin. Oncol. 14, 405 (1996).
6. J. D. Hood and D. A. Cheresh, Role of integrins in cell invasion and migration. Nat. Rev. Can. 2, 91 (2002).
7. P. C. Brooks, R. A. Clark, and D. A. Cheresh, Requirement of vascular integrin alpha υbeta 3 for angiogenesis. Science 264, 569 (1994).
8. C. L. Gladson, Expression of integrin avh3 in small blood vessels of glioblastoma tumors. J. Neuropathol. Exp. Neurol. 55, 1143 (1996).
9. 3-targeted radiotracers: Maximizing binding affinity via bivalency. Bioconjugate Chem. 20, 2199 (2009).
10. F. Xu, D. Lei, X. Du, C. Zhang, X. Xie, and D. Yin, Modification of MR molecular imaging probes with cysteine-terminated peptides and their potential for in vivo tumour detection. Contrast Media Mol. Imaging 6, 46 (2011).
11. Z. Liu and R. Peng, Inorganic nanomaterials for tumor angiogenesis imaging. Eur. J. Nucl. Med. Mol. Imaging 37 (Suppl 1), S147 (2010).
12. V. Koo, P. W. Hamilton, and K. Williamson, Non-invasive in vivo imaging in small animal research. Cell. Oncol. 28, 127 (2006).
13. W. Cai and X. Chen, Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 49 (Suppl 2), 113S (2008).
14. R. Weissleder and M. J. Pittet, Imaging in the era of molecular oncology. Nature 452, 580 (2008).
15. T. Skotland, T.-G. Iversen, and K. Sandvig, New metal-based nanoparticles for intravenous use: Requirements for clinical success with focus on medical imaging. Nanomedicine 6, 730 (2010).
16. M. Mahmoudi, V. Serpooshanb, and S. Laurent, Engineered nanoparticles for biomolecular imaging. Nanoscale 3, 3007 (2011).
17. D. W. Holdsworth and M. M. Thornton, Micro-CT in small animal and specimen imaging. Trends Biotechnol. 20, S34 (2002).
18. J. M. Kinsella, R. E. Jimenez, P. P. Karmali, A. M. Rush, V. R. Kotamraju, N. C. Gianneschi, E. Ruoslahti, D. Stupack, and M. J. Sailor, X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew. Chem. Int. Ed. 50, 12308 (2011).
19. I.-C. Sun, D.-K. Eun, H. Koo, C.-Y. Ko, H.-S. Kim, D. K. Yi, K. Choi, I. C. Kwon, K. Kim, and C.-H. Ahn, Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew. Chem. 123, 9520 (2011).
20. C. Wyss, S. C. Schaefer, L. Juillerat-Jeanneret, H.-A. Lehr, C. D. Becker, and X. Montet, Molecular imaging by micro-CT: Specific E-selectin imaging. Eur Radiol. 19, 2487 (2009).
21. Y. Wang, F. Xu, C. Zhang, D. Lei, Y. Tang, H. Xu, Z. Zhang, H. Lu, X. Du, and G.-Y Yang, High MR sensitive fluorescent magnetite nanocluster for stem cell tracking in ischemic mouse brain. Nanomedicine: NBM 7, 1009 (2011).
22. J. E. Rosen, L. Chan, D.-B. Shieh, and F X. Gu, Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine: NBM 8, 275 (2012).
23. D.-E. Lee, H. Koo, I.-C. Sun, J. H. Ryu, K. Kim, and I. C. Kwon, Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem. Soc. Rev. 41, 2656 (2012).
24. C. Zhang, M. Jugold, E. C. Woenne, T. Lammers, B. Morgenstern, M. M. Mueller, H. Zentgraf, M. Bock, M. Eisenhut, and W. Semmler, Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Research 67, 1555 (2007).
25. 3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner. Int. J. Nanomed. 4, 241 (2009).
26. C. Zhang, X. Xie, S. Liang, M. Li, Y. Liu, and H. Gu, Mono-dispersed high MR sensitive magnetite nano cluster probe for detection of nascent tumor by MR molecular imaging. Nanomedicine: NBM 8, 996 (2012).
27. X. Xie and C. Zhang, Controllable assembly of hydrophobic superparamagnetic iron oxide nanoparticle with mPEG-PLA copolymer and its effect on MR transverse relaxation rate. J. Nanomater 2011, Article ID 152524 (2010).
28. M. Irigoyen, M. J. Pajares, J. Agorreta, M. P. Ponz-Sarvisé, E. Salvo, M. D. Lozano, R. Pío, I. Gil-Bazo, and A. Rouzaut, RTeGseaFrcBh I expression is associated with a better response to chemotherapy in NSCLC. Mol. Cancer 9, 130 (2010).
29. J. Li, C. Zhang, K. Yang, P. Liu, and L. X. Xu, SPIO-RGD nanoparticles as molecular targeting probe for imaging tumor angiogenesis using synchrotron radiation. J. Synchrotron Rad. 18, 612 (2011).
30. A. Bumb, M. W. Brechbiel, P. L. Choyke, L. Fugger, A. Eggeman, D. Prabhakaran, J. Hutchinson, and P. J. Dobson, Synthesis and characterization of ultra-small superparamagnetic iron oxide nanoparticles thinly coated with silica. Nanotechnology 19, 335601 (2008).
31. S.-B. Yu and A. D. Watson, Metal-based x-ray contrast media, Chem. Rev. 99, 2353 (1999).
32. W. Krause, Delivery of diagnostic agents in computed tomography. Adv. Drug Deliv. Rev. 37, 159 (1999).
33. F. Hallouard, N. Anton, P. Choquet, A. Constantinesco, and T. Vandamme, Iodinated blood pool contrast media for preclinical X-ray imaging applications: A review, Biomaterials 31, 6249 (2010).
34. M. Shilo, T. Reuveni, M. Motiei, and R. Popovtzer, Nanoparticles as computed tomography contrast agents: Current status and future perspectives. Nanomedicine 7, 257 (2012).
35. A. Jakhmola, N. Anton, and T. F. Vandamme, Inorganic Nano-particles Based Contrast Agents for X-ray Computed Tomography, Adv. Healthcare Mater. (2012), Doi: 10.1002/adhm.201200032.
36. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. V. Elst, and R. N. Muller, Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064 (2008).
37. H. Mouaziz, R. Veyret, A. Theretz, F. Ginot, and A. Elaissari, Amin-odextran containing magnetite nanoparticles for molecular biology applications: Preparation and evaluation. J. Biomed. Nanotechnol. 5, 172 (2009).
38. L. L. C. Estevanato, L. M. Lacava, L. C. F. Carvalho, R. B. Azevedo, O. Silva, F. Pelegrini, S. N. Báo, P. C. Morais, and Z. G. M. Lacava, Long-term biodistribution and biocompatibility investigation of dextran-coated magnetite nanoparticle using mice as the animal model. J. Biomed. Nanotechnol. 8, 301 (2012).
39. L. H. Reddy, J. L. Arias, J. Nicolas, and P. Couvreur, Magnetic nanoparticles: Design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem. Rev. 112, 5818 (2012).
40. N. Weidner, J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli, and G. Gasparini, Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875 (1992).
41. J. Hasan, R. Byers, and G. C. Jayson, Intra-tumoural microvessel density in human solid tumours. Br. J. Cancer 86, 1566 (2002).
42. R. Misri, D. Meier, A. C. Yung, P. Kozlowski, and U. O. Häfeli, Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomedicine: NBM 8, 1007 (2012).
43. H. Hong, Y. Zhang, J. W. Engle, T. R. Nayak, C. P. Theuer, R. J. Nickles, T. E. Barnhart, and W. Cai, In vivo targeting and positron emission tomography imaging of tumor vasculature with 66Ga-labeled non-graphene. Biomaterials 33, 4147 (2012).
44. J. Xie, K. Chen, J. H. Huang, S. Lee, J. Wang, J. Gao, X. Li, and X. Chen, PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 30, 3016 (2010).
45. A. Xia, M. Chen, Y. Gao, D. Wu, W. Feng, and F. Li, Gd3 complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 33, 5394 (2012).